Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb;45(1):101-112.
doi: 10.1016/j.rdc.2018.09.007.

Challenges in Implementing Treat-to-Target Strategies in Rheumatology

Julia A Ford  1 , Daniel H Solomon  2
Affiliations
Review

Challenges in Implementing Treat-to-Target Strategies in Rheumatology

Julia A Ford et al. Rheum Dis Clin North Am. 2019 Feb.

Abstract

Despite evidence that treat-to-target (TTT) approaches lead to better disease outcomes in RA, TTT is not widely implemented in rheumatology clinics in North America. This article discusses the barriers (including access to care, patient and physician factors, and systems issues) to implementing TTT in the clinic, and proposes possible solutions and future research directions.

Keywords: Rheumatoid arthritis (RA); Treat-to-target; Treatment strategy.

PubMed Disclaimer

References

    1. Solomon DH, Bitton A, Katz JN, Radner H, Brown EM, Fraenkel L. Review: Treat to Target in Rheumatoid Arthritis: Fact, Fiction, or Hypothesis? Arthritis Rheumatol. 2014;66(4):775–782. doi:10.1002/art.38323 - DOI - PMC - PubMed
    1. Smolen JS, Aletaha D, Bijlsma JWJ, et al.Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69(4):631–637. doi:10.1136/ard.2009.123919 - DOI - PMC - PubMed
    1. Smolen JS, Breedveld FC, Burmester GR, et al.Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3–15. doi:10.1136/annrheumdis-2015-207524 - DOI - PMC - PubMed
    1. Singh JA, Furst DE, Bharat A, et al.2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012;64(5):625–639. doi:10.1002/acr.21641 - DOI - PMC - PubMed
    1. Smolen JS, Landewé R, Breedveld FC, et al.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis. 2014;73(3):492–509. doi:10.1136/annrheumdis-2013-204573 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances